BrainCo Inc.

BrainCo Inc.

Private
Somerville, MassachusettsHealthcare & Life Scienceshttp://www.brainco.tech

Last Round

IPO Announced

Jan 12, 2026

Est. Valuation

$1.3B

Total Funding Raised

$20.5M

Company Overview

BrainCo Inc. is a neurotechnology company that develops brain-computer interface (BCI) products, including prosthetic limbs and EEG headbands for brain signal monitoring and cognitive training.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Mental Health, Medical AI, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIneurotechnologynon-invasive BCIAI-powered prostheticsEEG wearablebrain techbionic handneurofeedbackbrainwave sensorassistive technologycognitive trainingmedical AISTEM education kitsthought-controlled devicessleep technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrainCo Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BrainCo Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
IPO AnnouncedJan 12, 2026
VC RoundAug 5, 2025
VC RoundFeb 25, 2025
Series AOct 26, 2017
Pre SeedDec 14, 2016

BrainCo Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 31, 2026

    Launched new 'FocusXin' Medical Edition at BCI conference in Beijing.

  • Jan 31, 2026

    Launched FocusXin Medical Edition for ADHD intervention on January 31, 2026.

BrainCo Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BrainCo Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BrainCo Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSomerville, Massachusetts
Employee Range103
Year Founded2015
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.